You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myxofibrosarcoma

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

Active, not recruiting
  • Advanced Soft Tissue Sarcoma
  • +26 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jan 6, 2023

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,

Recruiting
  • Sarcoma
  • +3 more
  • Isolated Limb Infusion
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 21, 2022

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021

Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

Unknown status
  • Sarcoma
  • +16 more
  • Sequential chemotherapy - 3 courses of AI
  • Hypofractionated radiotherapy
  • Warsaw, Mazovian, Poland
    Maria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021

Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,

Recruiting
  • Leiomyosarcoma
  • +29 more
  • Definitive Surgical Resection
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022

Sarcoma,Soft Tissue Trial in France (Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery, 2 cycles of

Recruiting
  • Sarcoma,Soft Tissue
  • Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery
  • +2 more
  • Bordeaux, France
  • +4 more
Mar 28, 2022

Leiomyosarcoma Trial in United States (TTI-621, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
  • +26 more
Jul 26, 2022

Soft Tissue Sarcoma of the Extremity Trial in Worldwide (Pembrolizumab)

Recruiting
  • Soft Tissue Sarcoma of the Extremity
  • Los Angeles, California
  • +18 more
Dec 15, 2022

Mixofibrosarcoma of the Extremities

Not yet recruiting
  • Sarcoma,Soft Tissue
  • case series review of clinical and histological data
  • (no location specified)
Jul 27, 2021

Soft Tissue Sarcoma Trial in New York (Doxorubicin, APX005M)

Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
Nov 12, 2021

Benign Tumor, Malignant Tumor Trial in Boston (Indocyanine green, SPY-PHI)

Recruiting
  • Benign Neoplasm
  • Malignant Neoplasm
  • Indocyanine green
  • SPY-PHI
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 20, 2023

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
Has Results
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor Trial in United States

Terminated
Has Results
  • High Grade Sarcoma
  • +18 more
  • Birmingham, Alabama
  • +459 more
Jul 27, 2022

Glabellar Lines Trial in France, Germany, United Kingdom (Botulinum toxin type A, Placebo)

Completed
Has Results
  • Glabellar Lines
  • Botulinum toxin type A
  • Placebo
  • Arras, France
  • +23 more
Sep 15, 2022

Acute Myeloid Leukemia Trial in France (IPH2102 at 0.1 mg/kg, IPH2102 at 1 mg/kg, Placebo (normal saline solution))

Completed
Has Results
  • Acute Myeloid Leukemia
  • IPH2102 at 0.1 mg/kg
  • +2 more
  • Amiens, France
  • +42 more
Sep 6, 2018

Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +268 more
Mar 12, 2020

Venous Thromboembolism Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Standard of Care)

Completed
Has Results
  • Venous Thromboembolism
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Standard of Care
  • Phoenix, Arizona
  • +108 more
Mar 13, 2020

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
Has Results
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +114 more
Aug 8, 2018

Geographic Atrophy Trial in Worldwide (Lampalizumab, Sham)

Terminated
Has Results
  • Geographic Atrophy
  • Birmingham, Alabama
  • +144 more
Jun 17, 2019

Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Athens, Alabama
  • +612 more
Dec 19, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alabaster, Alabama
  • +427 more
Jul 3, 2019

Cardiovascular Diseases Trial in Worldwide (Evacetrapib, Placebo)

Terminated
Has Results
  • Cardiovascular Diseases
  • Birmingham, Alabama
  • +443 more
Sep 25, 2019